Related references
Note: Only part of the references are listed.
Article
Virology
Mahmoud Kandeel et al.
Summary: The study investigates the evolutionary relationships and similarities between the Omicron variant and other SARS-CoV-2 variants, finding that the Omicron variant forms a new monophyletic clade distant from other variants.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Letter
Virology
Sohel Daria et al.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Review
Virology
Dandan Tian et al.
Summary: During the COVID-19 pandemic, various variants of SARS-CoV-2 have emerged, showing increased infectivity and immune escape, posing new challenges to epidemic prevention and control.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Editorial Material
Virology
Shou-Jiang Gao et al.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Article
Medicine, General & Internal
Tal Patalon et al.
Summary: This study demonstrated that receiving a booster dose of the BNT162b2 vaccine can reduce the odds of testing positive for SARS-CoV-2 in the short term, potentially counteracting waning immunity. Further monitoring is needed to determine the duration of immunity following the booster dose.
JAMA INTERNAL MEDICINE
(2022)
Article
Multidisciplinary Sciences
Jessica A. Plante et al.
Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.
Article
Biochemistry & Molecular Biology
Piyada Supasa et al.
Summary: Research on the UK-dominant variant B.1.1.7 shows that it is harder to neutralize than the parental virus, but widespread escape from antibodies or monoclonal antibodies has not been observed yet.
Editorial Material
Medicine, General & Internal
Arnaud Fontanet et al.
Article
Virology
Shang Yu Gong et al.
Summary: Towards the end of 2020, various variants of concern and interest emerged from the original SARS-CoV-2 strain, with a focus on mutations in the Spike protein and their impact on transmissibility, pathogenesis, and vaccine efficacy. Single mutations were found to have differential contributions to the global variants phenotype related to ACE2 interaction and antigenicity, with enhanced ACE2 interaction mainly being modulated by a decrease in off-rate. Additionally, it was observed that the Spike proteins from emerging variants bind better to ACE2 at 37 degrees C compared to the D614G variant.
Article
Multidisciplinary Sciences
Louise Dyson et al.
Summary: The viral reproduction of SARS-CoV-2 provides opportunities for acquiring advantageous mutations, and different mathematical models show that the epidemiological trajectories of potential VOCs depend on their transmissibility and immune escape capability. Variants with transmission advantages or immune escape properties can generate waves of infections, while variants with lower transmissibility but partial immune escape may only be revealed after further relaxation of control measures.
NATURE COMMUNICATIONS
(2021)
News Item
Medicine, General & Internal
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Review
Immunology
Lianlian Bian et al.
Summary: The Delta variant has caused a new wave of COVID-19 epidemic, requiring a higher proportion of the population to be vaccinated to reduce disease burden. Existing vaccines have shown decreased protective efficacy against the Delta variant, with a decline in neutralizing antibody titers post-vaccination. Accelerating vaccine coverage and intervention measures like mask-wearing are effective ways to control the spread of the Delta variant.
EXPERT REVIEW OF VACCINES
(2021)
Article
Medicine, General & Internal
Yinon M. Bar-On et al.
Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Multidisciplinary Sciences
M. Rafiul Islam et al.
SCIENTIFIC REPORTS
(2020)